T2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health's Center for Discovery and Innovation

Author's Avatar
Mar 25, 2020
Article's Main Image

New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument